wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38030595-7ABBB442-2917-4E9D-BE5B-1E82FBB5D59F
Q38030595-7ABBB442-2917-4E9D-BE5B-1E82FBB5D59F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38030595-7ABBB442-2917-4E9D-BE5B-1E82FBB5D59F
Current and emerging treatments in the management of castration-resistant prostate cancer.
P2860
Q38030595-7ABBB442-2917-4E9D-BE5B-1E82FBB5D59F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38030595-7ABBB442-2917-4E9D-BE5B-1E82FBB5D59F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ed2561e39cd7989abdcb7bb548a4030b96484e6
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.